N-Ethylhexedrone was patented by the German pharmaceutical firm Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[one]Disclaimer: The consequences listed underneath cite the Subjective Influence Index (SEI), an open up exploration literature dependant o